Friday, November 17, 2023 11:27:04 AM
From their last PR, I've updated the status on what was communicated:
• “Majority of the” MAA = completed
• “All but one of the key sections of the MAA” delivered to publisher = completed
• Finalization of last key section of the MAA (including “certain expert consultants”) = consultants to return week of Oct 30th [October 30th to November 3rd) - PENDING, unclear if this action was completed by Nov 3rd
• Remaining section of MAA package delivered to publisher within 2 weeks of consultant’s return = to be completed no later than November 17th - since DI said we would see a PR, we can assume this wasn't completed and is delayed!
• Publisher will need “two to three weeks” to complete their work on both the last portion and the integrated whole = to be completed approximately by December 1st or December 8th - assuming this will now be delayed day for day, putting completion now in the first or second week of December.
Goal posts. Continuing to be moved. DI. Continuing to misrepresent what's happening behind closed doors. IMHO opinion, we are looking for events to happen in January or well after. Don't mean to be skeptical, DI just built me this way.
• “Majority of the” MAA = completed
• “All but one of the key sections of the MAA” delivered to publisher = completed
• Finalization of last key section of the MAA (including “certain expert consultants”) = consultants to return week of Oct 30th [October 30th to November 3rd) - PENDING, unclear if this action was completed by Nov 3rd
• Remaining section of MAA package delivered to publisher within 2 weeks of consultant’s return = to be completed no later than November 17th - since DI said we would see a PR, we can assume this wasn't completed and is delayed!
• Publisher will need “two to three weeks” to complete their work on both the last portion and the integrated whole = to be completed approximately by December 1st or December 8th - assuming this will now be delayed day for day, putting completion now in the first or second week of December.
Goal posts. Continuing to be moved. DI. Continuing to misrepresent what's happening behind closed doors. IMHO opinion, we are looking for events to happen in January or well after. Don't mean to be skeptical, DI just built me this way.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
